Management of Elevated GTT at 27 Weeks Gestation
Start immediately with medical nutrition therapy (MNT) and self-monitoring of blood glucose, aiming for fasting glucose <95 mg/dL, 1-hour postprandial <140 mg/dL, or 2-hour postprandial <120 mg/dL; if these targets are not achieved within 1-2 weeks with lifestyle modifications alone, initiate insulin therapy as the first-line pharmacologic agent. 1, 2
Immediate First Steps
Confirm the Diagnosis
- The diagnosis of gestational diabetes mellitus (GDM) is confirmed when glucose values meet or exceed established thresholds on either the one-step 75-g OGTT (fasting ≥92 mg/dL, 1-hour ≥180 mg/dL, or 2-hour ≥153 mg/dL) or the two-step approach with 100-g OGTT. 1
- Only one abnormal value is required for diagnosis using the one-step strategy. 1
Initiate Lifestyle Modifications Immediately
- Refer to a registered dietitian familiar with GDM management to develop an individualized nutrition plan within the first week of diagnosis. 2
- The diet should provide minimum 175 g carbohydrate daily, 71 g protein daily, and 28 g fiber daily, emphasizing monounsaturated and polyunsaturated fats while limiting saturated fats and avoiding trans fats. 2
- Focus nutritional counseling on the type, amount, and distribution of carbohydrates, as blood glucose excursions depend primarily on carbohydrate intake. 3
- Prescribe at least 150 minutes of moderate-intensity aerobic activity weekly, spread throughout the week. 2
Blood Glucose Monitoring Protocol
Self-Monitoring Targets
- Fasting glucose: <95 mg/dL (5.3 mmol/L) 1, 2
- 1-hour postprandial: <140 mg/dL (7.8 mmol/L) OR 1, 2
- 2-hour postprandial: <120 mg/dL (6.7 mmol/L) 1, 2
Monitoring Frequency
- Check fasting glucose daily upon waking. 1
- Check postprandial glucose after each main meal (breakfast, lunch, dinner). 1
Decision Point: When to Add Pharmacologic Therapy
Timeline for Assessment
- Allow 1-2 weeks of intensive lifestyle modification with dietary counseling and glucose monitoring. 1, 2
- Approximately 70-85% of women diagnosed with GDM can achieve glycemic control with lifestyle modifications alone. 1, 2
Indications for Insulin Initiation
Start insulin if any of the following occur:
- Fasting glucose remains ≥95 mg/dL despite lifestyle modifications. 1
- More than 20% of postprandial glucose values exceed targets. 1
- Evidence of fetal macrosomia on ultrasound. 4
Pharmacologic Management
First-Line: Insulin Therapy
- Insulin is the preferred and recommended first-line pharmacologic agent because it does not cross the placenta to a measurable extent. 1, 2
- Insulin has been demonstrated to improve perinatal outcomes in large randomized studies. 1
Agents to AVOID as First-Line
- Do NOT use metformin as first-line therapy: It crosses the placenta with umbilical cord levels equal to or higher than maternal levels, and fails to provide adequate glycemic control in 25-28% of women with GDM. 1, 2
- Long-term safety data show 9-year-old offspring exposed to metformin were heavier with higher waist-to-height ratios than those exposed to insulin. 1
- Do NOT use glyburide as first-line therapy: It crosses the placenta (cord levels 50-70% of maternal levels), fails in 23% of women, and is associated with higher rates of neonatal hypoglycemia and macrosomia compared to insulin. 1, 2
Additional Management Considerations
Aspirin Prophylaxis
- Prescribe low-dose aspirin 81 mg/day by the end of the first trimester to lower the risk of preeclampsia in women with pre-existing diabetes risk factors. 1
Fetal Surveillance
- For women requiring insulin or other medications, initiate fetal surveillance starting at 32 weeks of gestation. 4
- Assess for fetal macrosomia (estimated fetal weight >4,000 g) as pregnancy progresses. 4
Delivery Planning
- For women controlling glucose with lifestyle modifications alone: plan delivery at 39/0 to 40/6 weeks of gestation. 4
- For women requiring medications: plan delivery at 39/0 to 39/6 weeks of gestation. 4
Common Pitfalls to Avoid
- Delaying dietitian referral: Immediate referral is critical as intensive dietary counseling is the cornerstone of successful GDM management. 2, 5
- Using oral agents as first-line therapy: Despite their convenience, metformin and glyburide have inferior outcomes and safety profiles compared to insulin. 1, 2
- Inadequate glucose monitoring frequency: Without proper monitoring, treatment effectiveness cannot be assessed and adjustments will be delayed. 2
- Waiting too long to initiate insulin: Women with greater initial hyperglycemia may require earlier pharmacological therapy; don't wait beyond 2 weeks if targets are not met. 2
Postpartum Follow-Up
- Test for persistent diabetes or prediabetes at 4-12 weeks postpartum using a 75-g OGTT with non-pregnancy diagnostic criteria. 1
- The OGTT is preferred over A1C because A1C may be falsely lowered by increased red blood cell turnover during pregnancy and blood loss at delivery. 1
- Women with a history of GDM have a 50-70% risk of developing type 2 diabetes over 15-25 years and require lifelong screening at least every 1-3 years. 1